CFO of Inovio Biomedical Corp. (INO, Financial) Peter Kies buys 25,000 shares of INO on 06/05/2012 at an average price of $0.41 a share.
Inovio Pharmac has a market cap of $57.2 million; its shares were traded at around $0.395 with and P/S ratio of 5.8.
For the complete insider trading history of INO, click here.
Inovio Pharmac has a market cap of $57.2 million; its shares were traded at around $0.395 with and P/S ratio of 5.8.
CEO Recent Trades:
- CEO, 10% Owner Jong Joseph Kim bought 50,000 shares of INO stock on 05/10/2012 at the average price of 0.48. Jong Joseph Kim owns at least 12,178,189 shares after this.
- CEO, 10% Owner Jong Joseph Kim bought 50,000 shares of INO stock on 03/22/2012 at the average price of 0.62. Jong Joseph Kim owns at least 12,128,189 shares after this.
Directors and Officers Recent Trades:
- COO Niranjan Sardesai bought 10,000 shares of INO stock on 05/16/2012 at the average price of 0.45. Niranjan Sardesai owns at least 76,800 shares after this.
- 10% Owner Austin W & Greenhouse Da Marxe sold 535,000 shares of INO stock on 12/13/2011 at the average price of 0.38. Austin W & Greenhouse Da Marxe owns at least 9,828,250 shares after this.
- 10% Owner Austin W & Greenhouse Da Marxe sold 760,000 shares of INO stock on 12/12/2011 at the average price of 0.39. Austin W & Greenhouse Da Marxe owns at least 10,363,250 shares after this.
For the complete insider trading history of INO, click here.
